CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Bank of America 37th Annual Investment Conference on Wednesday, September 19, 2007, at 3:30 p.m. PT at The Ritz Carlton Hotel in San Francisco.
